Latest News Live Updates: The recovery rate is 97.19 per cent.

New Delhi:

India’s COVID-19 infection tally climbed to 1,08,26,363 with 12,059 new cases in a day, while 1,05,122,601 people have recuperated so far pushing the national recovery rate to 97.19 per cent on Sunday, according to Union Health Ministry data.

There are 1,48,766 active cases of coronavirus infection in the country which accounts for 1.37 per cent of the total caseload, the data stated.

The death count climbed to 1,54,996 with the novel coronavirus virus claiming 78 lives in a span of 24 hours in the country, the data showed.

The COVID-19 case fatality rate stood at 1.43 per cent.

Meanwhile, Union Health Minister Harsh Vardhan has said that the country is developing seven more COVID-19 vaccines and also working on further vaccine development to inoculate every citizen of India.

He said the Centre does not have any immediate plan to make the vaccines available in the open market and a decision will be taken as the situation demands.

The COVID-9 inoculation process for people aged above 50 will start in March, he said.

“We are not dependent only on the two vaccines as the country is working on seven more indigenous vaccines. Simultaneously, we are also working on the development of more vaccines because India is a huge country and we need more players and research to reach out to everyone,” he said.

Here are Latest News Live Updates:

JustIn| 12,059 fresh coronavirus cases, 3% higher than yesterday; 1.05 crore people have recovered so far, 1.54 lakh total deaths

Farmers’ agitation against the three agriculture laws at Ghazipur border (Delhi-Uttar Pradesh border) enters Day 72.

Coronavirus LIVE Updates: Jharkhand logs 41 new COVID-19 cases, tally rises to 1,18,979

At least 41 more COVID-19 cases were registered in Jharkhand, raising the tally in the state to 1,18,979, a health department official said on Sunday.

The toll stood at 1,077, with no new death reported since Saturday, he said.

Of the 41 fresh cases, 25 were recorded in Ranchi, seven in Dumka and six in East Singhbhum.

Jharkhand currently has 428 active cases, while 1,17,474 people have recovered from the infection.

As many as 9,467 samples have been examined in the state since Saturday, the official added.

Meanwhile, the health department, in a report, said 9,915 more health workers were administered the COVID-19 vaccine in the last 24 hours.

Coronavirus News Updates: 282 new COVID-19 cases in Thane district, 4 more deaths

The COVID-19 tally in Maharashtra’s Thane district has gone up to 2,55,491 with the addition of 282 new cases of the infection, an official said on Sunday.

Apart from these cases reported on Saturday, four more people also succumbed to the viral infection, taking the death toll in the district to 6,178, he said.

The COVID-19 mortality rate in the district is 2.42 per cent, he said.

So far, 2,46,137patients have recuperated from the infection, taking the recovery rate in the district to 96.34 per cent, the official said.

PM Modi to launch ”Asom Mala”, lay foundation stone of two hospitals in Assam today

Prime Minister Narendra Modi on Sunday will lay the foundation stone of two hospitals and launch ”Asom Mala”, a programme for state highways and major district roads, at Dhekiajuli in Sonitpur district in Assam.

“I will be among the people of Assam tomorrow. At a programme in Dhekiajuli, Sonitpur district, the ”Asom Mala” programme will be launched, which will boost the state’s road infrastructure. This initiative will contribute to Assam’s economic progress and improve connectivity,” PM Modi tweeted.

“Foundation stones for medical colleges and hospitals in Biswanath and Charaideo will be laid. This will boost Assam”s health infrastructure. In the last few years, the state has made rapid strides in healthcare. This has benefitted not only Assam but also the entire Northeast,” he said in another tweet added.

Fire breaks out at Thane MSED office, no casualty reported

A fire broke out at the State Electricity Distribution Company office in Khajuri area of Thane district of Maharashtra on Sunday.

No casualty was reported in the incident that took place around 2.30 am today.

Police and fire tenders are present at the spot with two fire engines, two rescue vehicles, and four water tankers.

COVID-19 vaccines being sent to Afghanistan by a Mumbai-Delhi-Kabul Air India flight; visuals from Mumbai airport. #COVID19 vaccines being sent to Afghanistan by a Mumbai-Delhi-Kabul Air India flight

Visuals from Mumbai airport

(ANI)Rahul Gandhi to visit Rajasthan on February 12-13

Congress leader Rahul Gandhi is scheduled to visit Rajasthan on February 12 and February 13 to express solidarity with farmers’ who are protesting against the new agricultural laws of the Centre.

Rajasthan Congress in-charge Ajay Maken took to Twitter on Saturday to inform about Mr Gandhi’s visit.

“To fight for the interest of farmers, to raise the voice of the farmers, to participate in struggle against Central government demanding the repealing of three black laws, Rahul GandhiJi will come to Rajasthan on February 12 and 13,” Mr Maken posted on Twitter in Hindi.

Congress has been constantly supporting the farmers’ protest on Delhi borders against three farm laws passed by the Centre.

Oxford Covid Vaccine Less Effective Against South African Variant: Study

British drugmaker AstraZeneca said on Saturday its vaccine developed with the University of Oxford appeared to offer only limited protection against mild disease caused by the South African variant of COVID-19, based on early data from a trial.

The study from South Africa’s University of the Witwatersrand and Oxford University showed the vaccine had significantly reduced efficacy against the South African variant, according to a Financial Times report published earlier in the day.

Among coronavirus variants currently most concerning for scientists and public health experts are the so-called British, South African and Brazilian variants, which appear to spread more swiftly than others.

“In this small phase I/II trial, early data has shown limited efficacy against mild disease primarily due to the B.1.351 South African variant,” an AstraZeneca spokesman said in response to the FT report.

The newspaper said none of the more than 2,000 trial participants had been hospitalised or died.

Source link